Internal Medicine, Hematology & Oncology · Waldorf, MD
NPI
1255489027
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3261 Old Washington Road, Suite 1030
Waldorf, MD, 20602
Phone (301) 638-1007
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
371,336 services
Medicare patients, 2024
766
Average age 74
Drug cost, 2024
$6.8M
2,315 prescriptions
Company payments, 2025
$1,813
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by M Ashraf Meelu was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 111,690 times for 83 patients. In total M Ashraf Meelu billed 371,336 services in 108 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 111,690 | 83 | $0.27 | $30K |
| J0897 Injection, denosumab, 1 mg | Office | 13,500 | 84 | $9.97 | $135K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 12,520 | 81 | $3.81 | $48K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 10,768 | 42 | $0.07 | $727 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,920 | 13 | $5.40 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,860 | 67 | $0.09 | $343 |
| 85025 Blood Count | Office | 2,969 | 697 | $7.57 | $22K |
| 36415 Venipuncture Blood Collection | Office | 2,895 | 701 | $8.62 | $25K |
| 96372 Injection Administration | Office | 1,940 | 362 | $10.56 | $20K |
| 99213 Office E&M - Established | Office | 1,869 | 316 | $69.27 | $129K |
| 99214 Office E&M - Established | Office | 1,761 | 625 | $93.65 | $165K |
| 96375 Injection Administration | Office | 1,360 | 98 | $11.93 | $16K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,090 | 18 | $0.75 | $819 |
| 96367 Intravenous Infusion, Hydration | Office | 1,015 | 50 | $22.30 | $23K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 897 | 248 | $0.91 | $817 |
By year: 2022 $1.4M for 336,055 services; 2023 $1.7M for 333,375 services; 2024 $1.3M for 371,336 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,969 | 697 | $7.57 | $22K |
| 36415 Venipuncture Blood Collection | 2,895 | 701 | $8.62 | $25K |
Medicare prescription drug claims, 2024
In 2024, the drug M Ashraf Meelu prescribed most often to Medicare patients was Eliquis (Apixaban), with 244 prescriptions and refills. In total M Ashraf Meelu wrote 2,315 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 244 | 384 | 52 | $225K |
| Anastrozole Generic | 118 | 318 | 33 | $1,893 |
| Warfarin Sodium Generic | 98 | 210 | 12 | $1,126 |
| Retacrit Epoetin Alfa-Epbx | 89 | 91 | 28 | $175K |
| Xarelto Rivaroxaban | 84 | 194 | 19 | $105K |
| Hydroxyurea Generic | 72 | 159 | 17 | $2,396 |
| Oxycodone Hcl Generic | 67 | 67 | Under 11 | $1,106 |
| Acyclovir Generic | 57 | 92 | 14 | $1,095 |
| Olanzapine Generic | 57 | 92 | 20 | $1,596 |
| Levothyroxine Sodium Generic | 54 | 131 | 16 | $1,041 |
| Ondansetron Odt Ondansetron | 54 | 54 | 18 | $693 |
| Xgeva Denosumab | 53 | 99 | Under 11 | $176K |
| Dexamethasone Generic | 52 | 86 | 22 | $1,648 |
| Gabapentin Generic | 46 | 46 | Under 11 | $247 |
| Prednisone Generic | 40 | 56 | 15 | $259 |
Brand drugs: 983 claims; generic drugs: 1,332 claims; opioid claims: 188.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid M Ashraf Meelu $1,813 ($1,813 in general payments such as food, travel and fees) from 31 companies. The largest payer was Pfizer Inc. with $347.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $347 |
| Janssen Biotech, Inc. JNJ | 14 | $277 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $150 |
| Astellas Pharma US Inc 4503.T | 5 | $116 |
| Abbott Laboratories ABT | 1 | $112 |
| Genzyme Corporation SNY | 3 | $59.82 |
| Celgene Corporation BMY | 2 | $52.3 |
| Exelixis Inc. EXEL | 2 | $43.17 |
| Karyopharm Therapeutics Inc. KPTI | 2 | $42.11 |
| Aveo Pharmaceuticals, Inc. | 2 | $41.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.